Shares of Morepen Laboratories Ltd ended at ₹42.80, down by ₹1.86, or 4.16%, on the BSE.
Morepen Labs launches new cost-effective drug for diabetes, heart failure and kidney disease
Share it
Open an Account in less than 1 Min.
Need help? Call us
+916280171443
Services
Company
Get in touch
- +916280171443
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Marketrade Private Limited